Portnoy Law Firm Announces Class Action on Behalf of Vistagen Therapeutics, Inc. Investors
(NASDAQ:VTGN), LOS ANGELES, Jan. 22, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Vistagen Therapeutics, Inc., (“Vistagen” or the “Company”) (NASDAQ: VTGN) investors of a class action on behalf of investors that bought securities between April 1, 2024 and December 16, 2025, inclusive (the “Class Period”). Vistagen investors have until March 16, 2026 to […]